Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693207012 | Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3693208019 | Erythromycin 40 mg/g cutaneous gel | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | est un(e) (attribut) | Product containing only erythromycin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Plays role | Antibacterial therapeutic role (role) | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | est un(e) (attribut) | Product containing erythromycin in topical dosage form (medicinal product form) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | a pour principe actif (attribut) | Erythromycin (substance) | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | a pour principe actif (attribut) | Bactericide | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | a une forme pharmaceutique (attribut) | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | a une forme pharmaceutique (attribut) | Cutaneous gel | true | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has basis of strength substance (attribute) | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator unit | g | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator unit | milligram (qualifier value) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has precise active ingredient | Erythromycin (substance) | true | Inferred relationship | Some | 1 | |
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely erythromycin 40 milligram/1 gram conventional release cutaneous gel (clinical drug) | Has concentration strength numerator value (attribute) | 40 (qualifier value) | false | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR